BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 28067691)

  • 1. Dramatic Reduction in Tumor Size During 5 Months of Pazopanib Therapy in Combination With Ifosfamide, Carboplatin, and Etoposide in an Early Infant With Progressive Soft Tissue Sarcoma.
    Watanabe T; Kurata T; Sano K; Suzuki S; Kaneko T; Motobayashi M; Shigemura T; Sumi T; Koike K; Nakazawa Y
    J Pediatr Hematol Oncol; 2017 Mar; 39(2):154-156. PubMed ID: 28067691
    [No Abstract]   [Full Text] [Related]  

  • 2. Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.
    Chang AY; Boros L; Garrow GC; Asbury RF; Hui L
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):74-7. PubMed ID: 8677454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current strategy of chemotherapy for reflactory bone and soft tissue sarcomas].
    Chuman H
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1331-9. PubMed ID: 15446552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ifosfamide, carboplatin, and etoposide (ICE) reinduction chemotherapy in a large cohort of children and adolescents with recurrent/refractory sarcoma: the Children's Cancer Group (CCG) experience.
    Van Winkle P; Angiolillo A; Krailo M; Cheung YK; Anderson B; Davenport V; Reaman G; Cairo MS
    Pediatr Blood Cancer; 2005 Apr; 44(4):338-47. PubMed ID: 15503297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of advanced, high-grade soft-tissue sarcoma with ifosfamide and continuous-infusion etoposide.
    Saeter G; Talle K; Solheim OP
    Cancer Chemother Pharmacol; 1995; 36(2):172-5. PubMed ID: 7539339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of a combination of etoposide, ifosfamide, and cisplatin in the treatment of patients with soft tissue sarcoma.
    Pápai Z; Bodoky G; Szántó J; Poller I; Rahóty P; Eckhardt S; Láng I; Szendroi M
    Cancer; 2000 Jul; 89(1):177-80. PubMed ID: 10897015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of primary intracranial sarcoma with the ICE chemotherapy regimen and focal radiation in children.
    Lafay-Cousin L; Lindzon G; Taylor MD; Hader W; Hawkins C; Nordal R; Laperriere N; Laughlin S; Bouffet E; Bartels U
    J Neurosurg Pediatr; 2016 Mar; 17(3):298-302. PubMed ID: 26588458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ifosfamide, carboplatin and etoposide (ICE) as second-line regimen alone and in combination with regional hyperthermia is active in chemo-pre-treated advanced soft tissue sarcoma of adults.
    Fiegl M; Schlemmer M; Wendtner CM; Abdel-Rahman S; Fahn W; Issels RD
    Int J Hyperthermia; 2004 Sep; 20(6):661-70. PubMed ID: 15370821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the combination of ifosfamide and etoposide in the treatment of soft tissue sarcomas.
    Yalçin S
    Oncology; 1999; 57(2):175. PubMed ID: 10461067
    [No Abstract]   [Full Text] [Related]  

  • 10. A Systemic Hyperthermia Oncologic Working Group trial. Ifosfamide, carboplatin, and etoposide combined with 41.8 degrees C whole-body hyperthermia for metastatic soft tissue sarcoma.
    Westermann AM; Wiedemann GJ; Jager E; Jager D; Katschinski DM; Knuth A; Vörde Sive Vörding PZ; Van Dijk JD; Finet J; Neumann A; Longo W; Bakhshandeh A; Tiggelaar CL; Gillis W; Bailey H; Peters SO; Robins HI;
    Oncology; 2003; 64(4):312-21. PubMed ID: 12759526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I study of escalating doses of paclitaxel (Taxol) with fixed doses of ifosfamide, carboplatin, and etoposide.
    Boros L; Garrow GC; Asbury RF; Chang AY
    Semin Oncol; 1995 Jun; 22(3 Suppl 7):28-31. PubMed ID: 7610396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soft tissue sarcoma: an update on systemic treatment options for patients with advanced disease.
    Schöffski P; Cornillie J; Wozniak A; Li H; Hompes D
    Oncol Res Treat; 2014; 37(6):355-62. PubMed ID: 24903768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ifosfamide in soft tissue sarcoma.
    Zaidi SH; Iqbal Z; Mallick JA
    J Pak Med Assoc; 1990 Sep; 40(9):222-4. PubMed ID: 2123272
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial.
    Klingebiel T; Boos J; Beske F; Hallmen E; Int-Veen C; Dantonello T; Treuner J; Gadner H; Marky I; Kazanowska B; Koscielniak E
    Pediatr Blood Cancer; 2008 Apr; 50(4):739-45. PubMed ID: 18286501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of children with relapsed soft tissue sarcoma: report of the German CESS/CWS REZ 91 trial.
    Klingebiel T; Pertl U; Hess CF; Jürgens H; Koscielniak E; Pötter R; van Heek-Romanowski R; Rossi R; Schött C; Spaar HJ; Willnow U; Treuner J
    Med Pediatr Oncol; 1998 May; 30(5):269-75. PubMed ID: 9544222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of ifosfamide, carboplatin, and etoposide in children with solid tumors.
    Cairo MS
    Semin Oncol; 1995 Jun; 22(3 Suppl 7):23-7. PubMed ID: 7610395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ifosfamide, carboplatin and etoposide (ICE) combined with 41.8 degrees C whole body hyperthermia in patients with refractory sarcoma.
    Wiedemann GJ; Robins HI; Gutsche S; Mentzel M; Deeken M; Katschinski DM; Eleftheriadis S; Crahé R; Weiss C; Storer B; Wagner T
    Eur J Cancer; 1996 May; 32A(5):888-92. PubMed ID: 9081372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness of carboplatin and etoposide selective intra-arterial chemotherapy for progressive soft-tissue sarcoma].
    Hamana T; Takahashi M; Miyagi N
    Gan To Kagaku Ryoho; 2000 May; 27(5):729-34. PubMed ID: 10832442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial intense chemotherapy combining topotecan, etoposide, carboplatin and cyclophosphamide (TECC) followed by autologous hematopoietic stem cell support in patients with high risk soft tissue sarcoma (STS).
    Bernbeck B; Bahci S; Meisel R; Troeger A; Schönberger S; Laws HJ; Kramm C; Wessalowski R; Koscielniak E; Dilloo D; Göbel U
    Klin Padiatr; 2007; 219(6):318-22. PubMed ID: 18050041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ifosfamide, carboplatin, and etoposide in combination for induction and high-dose chemotherapy: focus on breast cancer and lymphoma.
    Fields KK; Elfenbein GJ; Saleh RA; Zorsky PE; Janssen WE; Perkins JB; Saleh TG; Piazza JT; Kronish LE; Machak MC
    Hematol Oncol; 1992; 10(1):61-74. PubMed ID: 1563705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.